Arkansas Blue Cross and Blue Shield · PayerPolicy · ARKBLUE-ANTI-TISSUE-FACTOR-PATHWAY-INHIBITORS-MARSTACIMAB-HNCQ-E-G-HYMPAVZI-AND-CONCIZUMAB-MTCI-E-G-ALHEMO
Summary of the payer’s published policy. Not a coverage determination — confirm with Arkansas Blue Cross and Blue Shield before submitting.
Free account. Policy pages stay open to everyone.
Each code’s status is what the policy records for it. This page does not show the policy’s criteria. Read them in the payer’s source.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Code | Code system | Status in this policy |
|---|---|---|
| J7172 | HCPCS | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| J7173 | HCPCS | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |